Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical studies

Diffusion-weighted Imaging Using 3.0 T MRI as a Possible Biomarker of Renal Tumors

HYNEK MIRKA, EVA KORCAKOVA, JAN KASTNER, MILAN HORA, ONDREJ HES, PETR HOSEK and JIRI FERDA
Anticancer Research April 2015, 35 (4) 2351-2357;
HYNEK MIRKA
1Department of Radiology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
5Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mirka@fnplzen.cz
EVA KORCAKOVA
1Department of Radiology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN KASTNER
1Department of Radiology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILAN HORA
2Department of Urology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ONDREJ HES
3Sikl's Department of Pathology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
5Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETR HOSEK
4Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
5Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIRI FERDA
1Department of Radiology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic
5Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Diffusion-weighted imaging (DWI) allows for differentiation of benign from malignant tumors, histological tumor types and their grade. The aim of the study was to evaluate the capabilities of DWI using 3 Tesla Magnetic resonance inaging (3T MRI) in the preoperative assessment of renal tumors. Patients and Methods: This retrospective study included 143 tumors in 139 patients (130 malignant tumors and 13 benign tumors) that were examined using DWI with b values of 50, 400 and 800 s/mm2. In all tumors, the lowest value of apparent diffusion coefficient (ADC) in the solid tissue was measured and correlated with the histological finding. Results: A significant difference between ADCs of malignant and benign tumors was found (p<0.001). Comparison of the most common malignant and benign tumors clear-cell renal carcinoma (CCRCC) grade I and oncocytoma resulted in a difference of borderline significance with a marked overlap (p=0.046). By assessing the histological types of malignant tumors, we detected a significant difference between CCRCC and all other histological types (p=0.048 for chromophobe (CH) RCC, p=0.002 for papillary (P) RCC and p=0.002 for urothelial carcinoma (UC)). Mutual differentiation of other types of carcinomas was not feasible (p=1.0 in all cases). The differences between low-grade (grade I+II) and high-grade (grade III+IV) CCRCC was significant (p<0.001). A significant difference was found even between CCRCC grade I and others (p=0.01 for grade II, p<0.001 for grade III+IV, respectively). Conclusion: DWI may contribute in distinguishing CCRCC from other histological types and to determinits grade. The method has certain potential for distinguishing benign from malignant tumors; however, differentiation of the most frequently represented types, CCRCC grade I and oncocytoma, remains difficult.

  • Renal tumor
  • magnetic resonance imaging
  • diffusion weighted MRI
  • apparent diffusion coefficient
  • biomarker

Worldwide, renal carcinomas represent approximately 3% of all malignancies (1). These tumors are most frequently encountered in developed countries of temperate climate, especially in Central and Eastern Europe. In the last twenty years, the detection rate of disease in the lower, asymptomatic stages has increased and improved the prognosis due to development of imaging techniques (2). However, despite improving imaging modalities, the differentiation between benign and malignant tumors in certain cases still remains a problem. According to published studies, benign tumors comprise up to one third of those resected (3, 4). An even bigger problem is the non-invasive differentiation between histological types of tumors and grade determination. Such information is important for the selection of appropriate therapeutic methods and prognosis estimation. For example, patients with clear-cell renal carcinoma (CCRCC) have a worse prognosis than patients with chromophobe (CHRCC) or papillary RCC (PRCC) (5, 6). In urothelial carcinoma (UC), different surgical treatments are used.

Modern imaging techniques allow for assessment of not only the morphological characteristics, such as size, contrast enhancement and relationship to surrounding structures, but also functional and molecular parameters. One of the parameters is the diffusion of water molecules, which can be evaluated using diffusion-weighted magnetic resonance imaging (DW MRI). This method has previously been associated almost entirely with imaging of cerebral pathologies. Due to the use of stronger gradients and faster pulse sequences, DW MRI has recently been used more frequently in other organs, especially in oncological indications. Application of diffusion-weighted imaging to characterize the tissue is based on differences of diffusion of water molecules in benign and malignant lesions (Figure 1). The reason for this difference has not been yet fully explained. It is assumed that this difference is caused by tumor cellularity, extracellular space turtuosity, degree of tissue disorganization and, presumably, the cellular structure (7, 8). Diffusion-weighted imaging (DWI) can also be affected by perfusion (9, 10).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

MRI examination protocol.

Images are obtained using diffusion-weighted sequences (the most common imaging is echo planar imaging (EPI)) with different b-values. The b-value expresses the impact of gradients on diffusion-weighted images. The higher the b-value is, the greater the diffusion weighting and, subsequently, the sensitivity of the movement of water are. To express the rate of diffusion of water molecules, an apparent diffusion coefficient (ADC) is used, which is expressed in unit mm2/s (11). The ADC values are automatically calculated from diffusion-weighted images with at least two b-values and they are expressed either numerically or using the grayscale parametric maps.

The aim of the present study is to assess the possibility of diffusion-weighted imaging for the preoperative determination of dignity, histological type and grade of renal tumors using 3.0 Tesla (3T) MRI and comparison of the results with previously published studies.

Patients and Methods

From a group of 161 patients, who underwent MRI of kidneys for a suspected tumor between 2011-2014, we selected 139 patients with 143 tumors (61 females, 78 males, average age 65 years, range=37-86 years). Twenty-two patients with cysts (n=15), typical angiomyolipomas with fat content (n=5) and low quality DWI (n=2) were excluded. All tumors were resected and examined by a pathologist who is specialized in assessment of kidney tumors. In addition, for CCRCC the grade was specified according to Fuhrman (12).

All the examinations were carried-out with the 3.0 T MR scanner Siemens Magnetom Skyra (Siemens, Erlangen, Germany) using the matrix body coil with the standard protocol of our department for imaging of the renal carcinoma. Diffusion weighted images were obtained using echo planar sequences with b values of 50, 400 and 800 s/mm2. From these three values, we automatically generated parametric maps of ADC, which were used to measure numeric values (Table I).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Example of two patients with oncocytoma (A, B) and clear-cell RCC grade I (C, D). A similar appearance in postcontrast T1 weighted images (A, C) is observed. Apparent diffusion coeficient maps show high value for oncocytoma (1.868×10-3 mm2/s) (C) and low value for clear-cel RCC (1.37×10-3 mm2/s) (D).

Image analysis was performed retrospectively by the two radiologists with 11 and 4 years of experience in the field of abdominal MRI without knowledge of the histological findings. For each tumor, three to five circular areas of interest with a diameter of at least 1 cm were selected based on the size of the tumor. The areas of interest had been selected to include only the solid tissue with contrast enhancement. Based on consensus, both radiologists selected areas of interest with the lowest value of the ADC that was included in the statistical analysis.

Statistical analysis was carried-out using the Statistica software (StatSoft, Tulsa, OK, USA). Due to the non-normal distribution of the ADC values, non-parametric methods were used. Assessment of the differences between the two groups of tumors (between malignant and benign tumors and between low-grade CCRCC and oncocytoma) was performed using the Mann-Whitney U test. For the assessment of the difference in the ADC among other carcinoma groups (individual histological types of tumors and the grade of CCRCC), we used the Kruskal-Wallis ANOVA test. The difference between the ADC of tumors and normal renal parenchyma was assessed using the Wilcoxon paired test. The Fischer exact test was used for testing of the impact tumor grade on the differentiation of various histological types. In all cases, the significance level of 5% was predetermined.

Results

In total, 130 malignant tumors were found. This number included 123 RCC and 7 intrarenal UC. The most frequent histological variant of RCC was CCRCC (n=102). CHRCC and PRCC were represented significantly less (n=8 and n=14, respectively). Furthermore, the CCRCCs were divided according to the grade. Grade I (n=48) was the most frequently encountered grade; the number of carcinomas of grades II and III accounted for approximately half (n=25 and n=27, respectively). There was a very small number of grade IV carcinomas (n=2). Thirteen benign carcinomas included 11 oncocytomas and 2 mixed epithelial and stromal tumors. Measured ADC values are summarized in Table II.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Box and Whisker plot of ADC values difference of malignant and benign tumors from normal renal parenchyma shows significant difference between both groups of tumors. The difference between benign tumors and renal parenchyma is, contrary to malignant tumors, insignificant.

Differentiation between benign and malignant tumors. Compared to the normal renal parenchyma in malignant and benign tumors, a tendency towards a lower ADC was found (median=1.825, interquartile range (IQR)=0.118×10-3 mm2/s vs. median=1.305, IQR=0.365×10-3 mm2/s and median= 1.671, IQR=0.415×10-3 mm2/s, respectively). The difference was significant for malignant tumors (p<0.005). In the benign tumors, the difference between the ADC in tumors and renal parenchyma was insignificant (p=0.10) (Figure 2). The difference between the ADC values of all the malignant and benign tumors was significant (p<0.001) (Figure 3). Since CCRCC grade I, which was the most common type of malignant tumor in the group, had the highest ADC value of all malignant tumors (median=1.467, IQR=0.201×10-3 mm2/s), we compared this group with the most common benign tumor-oncocytoma (median=1.652, IQR=0.362×10-3 mm2/s). In this case, the difference was only on the border of statistical significance (p=0.046) with a marked overlap of ADC values (Figure 4).

Differentiation of histological types of tumors. We observed a tendency towards a decrease in the ADC from CCRCC (median=1.365, IQR=0.302×10-3 mm2/s) over CHRCC (median=1.068, IQR=0.232×10-3 mm2/s) and PRCC (median= 1.006, IQR=0.549×10-3 mm2/s) to UC (median= 1.028, IQR=0.189×10-3 mm2/s). The ADC in CCRCC was significantly higher than in any of the other groups. For CHRCC, the finding achieved the border of statistical significance (p=0.048), in PRCC (p=0.002) and UC (p=0.002) the finding was unambiguously significant. The mutual difference between CHRCC, PRCC and UC was not significant (p=1.0 in all cases) (Figure 5). In addition, it excluded that the differentiation of histological types of carcinomas was affected by the unequal representation of grade in each group (p=1.00).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Box and Whisker plot of ADC values in all malignant and benign tumors shows significant difference.

Differentiation of grade. Statistical analysis of the grade of tumors was performed only in CCRCC. The results show that an increase in the grade of the tumor causes a tendency to reduce the value of the ADC. At first, the differences between tumors of high (grade I+II) and low grades (grade III+IV) were assessed (median=1.430 vs. 1.189×10-3 mm2/s, p<0.001) (Figure 6). The result was statistically significant (p<0.001). A significant difference was found also between tumors of grade I and other grades (median=1.324, IQR=0.283×10-3 mm2/s, p=0.01 for grade II and median= 1.189, IQR=0.290×10-3 mm2/s, p<0.001 for grade III+IV, respectively). The grade II tumors did not differ significantly from grade III and IV tumors (p=0.057). In this group, there were only two grade IV tumors; therefore, this group was not assessed separately (Figure 7).

Discussion

According to the authors' best knowledge, this is the largest published set of renal carcinomas examined using DW MRI from a single center.

Due to the expected higher quality of diffusion-weighted images, we used the 3T system and calculated the ADC value from three b-values, with the highest b value at 800 s/mm2 (8, 13). The considerable heterogeneity in structure can cause a problem in the assessment of diffusion in the renal tumors. A recommended technique for analysis of diffusion-weighted images has not been established; therefore, the approach of individual authors differs. In recent studies, the area of interest is focused on a solid portion of the lesion. Subsequently, the mean value (14-16) or the lowest ADC value (9, 17-21) have been assessed by measuring multiple areas, with the number of considered areas depending on the size of the tumor. In one study, the authors focused on a histogram of the entire lesion to distinguish RCC and angiomyolipoma without visible fat content (22). Our technology of ADC assessment was based on selection of one area of interest with the lowest measured value, which in our opinion is appropriate for routine clinical assessment. We chose the region of interest for ADC measurement based on the consensus of two radiologists; therefore, analysis of interobserver agreement was not performed.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Box and Whisker plot of ADC values in clear-cell RCC grade I and oncocytoma shows difference of borderline significance.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Box and Whisker plot of ADC values in different types of malignant tumors. Difference between clear cell RCC and chromophobe RCC is of borderline significance, difference between clear cel RCC and other tumor is clearly significant.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Box nad Whisker plot of ADC values in low-grade (GI+GII) ahd high-grade (GIII+G IV) clear cell RCCs shows significant difference.

Comparison of ADC for each lesion with other studies is difficult due to differences in the equipment used and the design of diffusion-weighted sequences. This can be documented with the mean ADC in the renal parenchyma. In recent literature, these values vary between 1.64×10-3 and 2.35×10-3 mm2/s (14, 15, 18-23). In our group of patients, we found a median of 1.825×10-3 mm2/s with an IRQ of 0.118×10-3 mm2/s. Similar differences can be observed even in pathological lesions (24).

Preoperative differentiation between benign and malignant tumors has been an ongoing problem. Some of the earlier publications have shown that DWI can be particularly useful in differentiating oncocytomas, which may look similar to carcinomas on other types of MR imaging (24). We proved a statistically significant difference in ADC values between all benign and malignant tumors (p<0.001). When we assessed the most frequently abundant malignant tumors with the highest ADC values (CCRCC G I) and the most frequently benign tumor (oncocytoma) in isolation, the result had borderline statistical significance (p=0.046) with marked overlap. This finding demonstrates the problematic utility of ADC for safe differentiation of these two entities, which is also mentioned in another study with 10 oncocytomas from one center (14). In other studies, which present significant differences, the oncocytomas were represented only in very small numbers; therefore, the results might be distorted (16, 19, 25-27). An interesting fact is that cellularity, which is significantly higher than in CHRCC, does not become a factor determining the diffusion of water molecules in oncocytoma (19). The group of benign lesions did not include cysts and angiomyolipoma that could be specifically distinguished by the presence of liquid or fat by other sequences and the ADC is either significantly higher (cysts) or lower (angiomyolipoma) and could modify the results.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Box and Whisker plot of ADC values distribution among clear cell RCC grade I, grade II and grade III+IV. Insignificant difference between grade II and grade III+IV; other differences are significant.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Apparent diffusion coefficients in renal parenchyma and different tumor types.

When differentiating the histological types of carcinoma, we found higher ADC values in CCRCC compared to all other malignant tumors, similar to most published studies (15, 18, 21, 22). In our group, the difference was statistically significant. Other histological types of tumors were not distinguishable based on measurements of ADC to distinguish. Slightly higher, but not significantly different, the values are still found in CHRCC. This result does not correlate with histological characteristics of presented tumors because CCRCC has a higher cellularity than PRCC and CHRCC. A likely explanation is the difference in perfusion, which also affects the diffusion-weighted images. CHRCC and PRCC are typically hypovascular compared to CCRCC (15, 22, 28). We did not even prove significant difference between UC and non-clear RCCs (p=1.00). This is most likely related to the higher cellularity of this tumor type. The surprising fact is represented in this year's published study that presents a significantly higher ADC in CHRCC and PRCC than in CCRCC (1.59±0.55×10-3 mm2/s vs. 6.72±1.85×10-3 mm2/s) (18). To our knowledge, this observation is unique.

In the observed group, a tendency to decrease the ADC was correlated with increasing tumor grade. Using the simplified differentiation of the low-grade and high-grade tumors, which is recommended to reduce the variability among observers assessing the histology (29), the difference was statistically very significant. A significant difference was even observed between grade I and grade II tumors (p=0.01). Grade II tumors did not show a significant difference compared to grade III+IV. The assessment of the grade according to Fuhrman is important, particularly in CCRCC, where it is based on the morphology of the cell nuclei and does not have a direct link with the cellularity of the tumor. Low-grade tumors have large cells with large amounts of glycogen, unlike the higher-grade tumors with less amount of glycogen and more organelles. It is possible that this difference affects intracellular diffusion, which may also contribute to the value of the ADC (9).

The presented study suffers four main limitations. The first one is its retrospective character. The second one is based on the unequal representation of different histolo gical variants of carcinomas arising from their prevalence (30). A third limitation is represented with the absence of interobserver agreement, an important point that has to be aimed at due to the great heterogeneity of carcinoma structures and inconsistent methodology for future separate studies. The fourth limitation is represented by an independent ADC assessment, without other types of MR imaging that could contribute to better differentiation of the individual groups.

Conclusion

Assessment of diffusion of water molecules in renal tumors using ADC may help to distinguish CCRCC from other histological variants of renal carcinomas and to determine its grade. The method has also some potential for differentiating benign from malignant tumors, especially between the most common representatives, oncocytoma and CCRC grade I. It is not currently possible to reduce the number of unnecessary resections of these benign lesions based on ADC assessment. To use DWI in common practice, it is necessary to define a suitable and proper methodology for measuring ADC. Due to differences of measured values using different equipment and different designs of pulse sequences, we can determine limit values transferable within differently equipped institutions.

Acknowledgements

Supported by the project of the Ministry of Health - Conceptual Development of research institutions 00669806-FN Plzen, by research project IGA MZ ČR 13326 (2012-2015) and by the project CZ.1.05/2.1.00/03.0076 from European Regional Development Fund.

  • Received December 15, 2014.
  • Revision received January 11, 2015.
  • Accepted January 16, 2015.
  • Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Chow WH,
    2. Dong LM,
    3. Devesa SS
    : Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257, 2010.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Tsui KH,
    2. Shvarts O,
    3. Smith RB,
    4. Figlin R,
    5. Kernion JB,
    6. Belldegrun A
    : Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 163: 426-430, 2000.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Snyder ME,
    2. Bach A,
    3. Kattan MW,
    4. Raj GV,
    5. Reuter VE,
    6. Russo P
    : Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176: 2391-2395, 2006.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Marszalek M,
    2. Ponholzer A,
    3. Brössner C,
    4. Wachter J,
    5. Maier U,
    6. Madersbacher S
    : Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients: Urology 64: 38-42, 2004.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Patard JJ,
    2. Leray E,
    3. Rioux-Leclercq N,
    4. Cindolo L,
    5. Ficarra V,
    6. Zisman A,
    7. De La Taille A,
    8. Tostain J,
    9. Artibani W,
    10. Abbou CC,
    11. Lobel B,
    12. Guillé F,
    13. Chopin DK,
    14. Mulders PFA,
    15. Wood CG,
    16. Swanson DA,
    17. Figlin RA,
    18. Belldegrun AS,
    19. Pantuck AJ
    : Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23: 2763-2771, 2005.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Steffens S,
    2. Janssen M,
    3. Roos FC,
    4. Becker F,
    5. Schumacher S,
    6. Seidel C,
    7. Wegener G,
    8. Thüroff JW,
    9. Hofmann R,
    10. Stöckle M,
    11. Siemer S,
    12. Schrader M,
    13. Hartmann A,
    14. Kuczyk MA,
    15. Junker K,
    16. Schrader AJ
    : Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma-a multicentre study. Eur J Cancer 48: 2347-2352, 2012.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Thoeny HC,
    2. De Keyzer F
    : Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 17: 1385-1393, 2007.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Padhani AR,
    2. Liu G,
    3. Mu-Koh D,
    4. Chenevert TL,
    5. Thoeny HC,
    6. Takahara T,
    7. Dzik-Jurasz A,
    8. Ross BD,
    9. Van Cauteren M,
    10. Collins D,
    11. Hammoud DA,
    12. Rustin GJS,
    13. Taouli B,
    14. Choyke PL
    : Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11: 102-125, 2009.
    OpenUrlPubMed
  9. ↵
    1. Rosenkrantz AB,
    2. Niver BE,
    3. Fitzgerald EF,
    4. Babb JS,
    5. Chandarana H,
    6. Melamed J
    : Utility of the apparent diffusion coefficient for distinguishing clear cell cenal cell carcinoma of low and high nuclear grade. Am J Roentgenol 195: W344-W351, 2010.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fukuda Y,
    2. Ohashi I,
    3. Hanafusa K,
    4. Nakagawa T,
    5. Ohtani S,
    6. Annaka Y,
    7. Hayashi T,
    8. Shibuya H
    : Anisotropic diffusion in kidney: apparent diffusion coefficient measurements for clinical use. JMRI-J Magn Reson Im 11: 156-160, 2000.
    OpenUrl
  11. ↵
    1. El Kady RM,
    2. Choudhary AK,
    3. Tappouni R
    : Accuracy of apparent diffusion coefficient value measurement on PACS work station: a comparative analysis. Am J Roentgenol 196: W280-W284, 2011.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Fuhrman SA,
    2. Lasky LC,
    3. Limas C
    : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-63, 1982.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Kingsley PB,
    2. Monahan WG
    : Selection of the Optimum b factor for diffusion-weighted magnetic resonance imaging assessment of ischemic stroke. MRM 51: 996-1001, 2004.
    OpenUrl
  14. ↵
    1. Sevcenco S,
    2. Heinz-Peerb G,
    3. Ponholdb L,
    4. Javorb D,
    5. Kuehhasa FE,
    6. Klinglera HC,
    7. Remzia M,
    8. Weibla P,
    9. Shariata SF,
    10. Baltzerb PA
    : Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors. Eur J Radiol 83: 909-913, 2014.
    OpenUrlPubMed
  15. ↵
    1. Goyal A,
    2. Sharma R,
    3. Bhalla AS,
    4. Gamanagatti S,
    5. Seth A,
    6. Iyer VK,
    7. Das P
    : Diffusion-weighted MRI in renal cell carcinoma: A surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 53: 349-358, 2012.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Zhang J,
    2. Tehrani YM,
    3. Wang L,
    4. Ishill NM,
    5. Schwartz LH,
    6. Hricak H
    : Renal masses: characterization with diffusion-weighted MR imaging-a preliminary experience. Radiology 247: 458-464, 2008.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Sandrasegaran K,
    2. Sundaram CP,
    3. Ramaswamy R,
    4. Akisik FM,
    5. Rydberg MP,
    6. Lin C,
    7. Aisen AM
    : Usefulness of diffusion-weighted imaging in the evaluation of renal masses. Am J Roentgenol 194: 438-445, 2010.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Paudyal B,
    2. Paudyal P,
    3. Tsushima Y,
    4. Oriuchi N,
    5. Amanuma M,
    6. Miyazaki M,
    7. Taketomi-Takahashi A,
    8. Nakazato Y,
    9. Endo K
    : The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J radiol 83: 336-343, 2010.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Squillaci E,
    2. Manenti G,
    3. Cova M,
    4. Di Roma M,
    5. Miano R,
    6. Palmieri G,
    7. Simonetti G
    : Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer res 24: 4175-4180, 2004.
    OpenUrlAbstract/FREE Full Text
    1. Squillaci E,
    2. Manenti G,
    3. Di Stefano F,
    4. Miano R,
    5. Strigari L,
    6. Simonetti G
    : Diffusion-weighted MR imaging in the evaluation of renal tumours. J Exp Clin Cancer Res 23: 39-45, 2004.
    OpenUrlPubMed
  20. ↵
    1. Wang H,
    2. Cheng L,
    3. Zhang X,
    4. Wang D,
    5. Guo A,
    6. Gao Y,
    7. Ye H
    : Renal Cell Carcinoma: Diffusion weighted MR Imaging for Subtype Differentiation at 3.0 T. Radiology 257: 135-143, 2010.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Tanaka H,
    2. Yoshida S,
    3. Fujii Y,
    4. Ishii C,
    5. Tanaka H,
    6. Koga F,
    7. Saito K,
    8. Masuda H,
    9. Kawakami S,
    10. Kihara K
    : Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol 18: 727-730, 2011.
    OpenUrlPubMed
  22. ↵
    1. Manenti G,
    2. Di Roma M,
    3. Mancino S,
    4. Bartolucci DA,
    5. Palmieri G,
    6. Mastrangeli R,
    7. Miano R,
    8. Squillaci E,
    9. Simonetti G
    : Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3T. Radiol Med 113: 199-213, 2008.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Lassel EA,
    2. Rao R,
    3. Schwenke C,
    4. Schoenberg SO,
    5. Michaely HJ
    : Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol 24: 241-249, 2014.
    OpenUrlPubMed
  24. ↵
    1. Doganay S,
    2. Kocakoc E,
    3. Cicekci M,
    4. Aglamis S,
    5. Akpolat N,
    6. Orhan I
    : Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions. Clin Radiol 66: 420-425, 2011.
    OpenUrlCrossRefPubMed
    1. Inci E,
    2. Hocaoglu E,
    3. Aydin S,
    4. Cimilli T
    : Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol 81: 815-820, 2012.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Razek AA,
    2. Farouk A,
    3. Mousa A,
    4. Nabil N
    : Role of diffusion weighted magnetic resonance imaging in characterization of renal tumors. J Comput Assist Tomogr 35: 332-336, 2011.
    OpenUrlPubMed
  26. ↵
    1. Taouli B,
    2. Thakur RK,
    3. Mannelli L,
    4. Babb JS,
    5. Kim S,
    6. Hecht EM,
    7. Lee VS,
    8. Israel GM
    : Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251: 398-407, 2009.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Lang H,
    2. Lindner V,
    3. de Fromont M,
    4. Molinié V,
    5. Letourneux H,
    6. Meyer N,
    7. Martin M,
    8. Jacqmin D
    : Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with >15-year follow-up. Cancer 103: 625-629, 2005.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Prasad SR,
    2. Humphrey PA,
    3. Catena JR,
    4. Narra VR,
    5. Srigley JR,
    6. Cortez AD,
    7. Dalrymple NC,
    8. Chintapalli KN
    : Common and Uncommon Histologic Subtypes of Renal Cell Carcinoma: Imaging Spectrum with Pathologic Correlation. RadioGraphics 26: 1795-1810, 2006.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 35 (4)
Anticancer Research
Vol. 35, Issue 4
April 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diffusion-weighted Imaging Using 3.0 T MRI as a Possible Biomarker of Renal Tumors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Diffusion-weighted Imaging Using 3.0 T MRI as a Possible Biomarker of Renal Tumors
HYNEK MIRKA, EVA KORCAKOVA, JAN KASTNER, MILAN HORA, ONDREJ HES, PETR HOSEK, JIRI FERDA
Anticancer Research Apr 2015, 35 (4) 2351-2357;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Diffusion-weighted Imaging Using 3.0 T MRI as a Possible Biomarker of Renal Tumors
HYNEK MIRKA, EVA KORCAKOVA, JAN KASTNER, MILAN HORA, ONDREJ HES, PETR HOSEK, JIRI FERDA
Anticancer Research Apr 2015, 35 (4) 2351-2357;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Keywords

  • Renal tumor
  • magnetic resonance imaging
  • diffusion weighted MRI
  • apparent diffusion coefficient
  • biomarker
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire